Suppr超能文献

原发性进行性失语亚组中的阿尔茨海默病和额颞叶病理学。

Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia.

作者信息

Mesulam Marsel, Wicklund Alissa, Johnson Nancy, Rogalski Emily, Léger Gabriel C, Rademaker Alfred, Weintraub Sandra, Bigio Eileen H

机构信息

Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

出版信息

Ann Neurol. 2008 Jun;63(6):709-19. doi: 10.1002/ana.21388.

Abstract

OBJECTIVE

To identify predictors of Alzheimer's disease (AD) versus frontotemporal lobar degeneration pathology in primary progressive aphasia (PPA), and determine whether the AD pathology is atypically distributed to fit the aphasic phenotype.

METHODS

Neuropsychological and neuropathological analyses of 23 consecutive PPA autopsies. All had qualitative determination of neurofibrillary tangle (NFT) density. Additional quantitation was done in four of the PPA/AD cases and four AD cases with the typical amnestic dementia of the Alzheimer type.

RESULTS

The sample contained mostly logopenic, agrammatic, and mixed forms of PPA. All six agrammatics had frontotemporal lobar degeneration (five of six with tauopathy). Seven of the 11 logopenics had AD. In logopenics, lower memory scores increased the probability of AD, but there were exceptions. The PPA/AD group showed predominance of entorhinal NFT typical of the amnestic dementia of the Alzheimer type. In the small subgroup examined quantitatively, neocortical NFTs were more numerous in the left hemisphere of PPA/AD. However, the asymmetry was low and inconsistent. Neuritic plaques did not display consistent asymmetry. Apolipoprotein E4, a major risk factor for typical AD, did not predict AD pathology in PPA.

INTERPRETATION

Subtyping PPA helps to predict AD versus frontotemporal lobar degeneration pathology at the group level. However, our results and the literature also indicate that no clinical predictor is completely reliable in individual patients. The inconsistent concordance of NFT distribution with the asymmetric atrophy and the nonamnestic phenotype also raises the possibility that the AD markers encountered at autopsy in PPA may not always reflect the nature of the initiating neurodegenerative process.

摘要

目的

识别原发性进行性失语(PPA)中阿尔茨海默病(AD)与额颞叶变性病理的预测因素,并确定AD病理是否呈非典型分布以符合失语表型。

方法

对23例连续的PPA尸检进行神经心理学和神经病理学分析。所有病例均对神经原纤维缠结(NFT)密度进行了定性测定。对4例PPA/AD病例和4例典型阿尔茨海默型遗忘性痴呆的AD病例进行了额外的定量分析。

结果

样本主要包含语音性失语、语法性失语和混合型PPA。所有6例语法性失语患者均有额颞叶变性(6例中有5例为tau蛋白病)。11例语音性失语患者中有7例患有AD。在语音性失语患者中,较低的记忆分数增加了患AD的可能性,但也有例外。PPA/AD组显示出典型阿尔茨海默型遗忘性痴呆的内嗅区NFT占优势。在进行定量检查的小亚组中,PPA/AD患者左半球的新皮质NFT更多。然而,这种不对称性较低且不一致。神经炎性斑块未表现出一致的不对称性。载脂蛋白E4是典型AD的主要危险因素,但不能预测PPA中的AD病理。

解读

对PPA进行亚型分类有助于在群体水平上预测AD与额颞叶变性病理。然而,我们的结果和文献也表明,在个体患者中没有临床预测指标是完全可靠的。NFT分布与不对称萎缩和非遗忘性表型的不一致性也增加了在PPA尸检中遇到的AD标志物可能并不总是反映起始神经退行性过程本质的可能性。

相似文献

1
Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia.
Ann Neurol. 2008 Jun;63(6):709-19. doi: 10.1002/ana.21388.
2
Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia.
Brain. 2012 May;135(Pt 5):1554-65. doi: 10.1093/brain/aws076. Epub 2012 Apr 19.
3
Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease.
Brain Pathol. 2020 Mar;30(2):332-344. doi: 10.1111/bpa.12783. Epub 2019 Sep 12.
4
Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia.
Brain. 2014 Apr;137(Pt 4):1176-92. doi: 10.1093/brain/awu024. Epub 2014 Feb 25.
5
Memory Resilience in Alzheimer Disease With Primary Progressive Aphasia.
Neurology. 2021 Feb 9;96(6):e916-e925. doi: 10.1212/WNL.0000000000011397. Epub 2021 Jan 13.
7
Asymmetric TDP-43 distribution in primary progressive aphasia with progranulin mutation.
Neurology. 2010 May 18;74(20):1607-10. doi: 10.1212/WNL.0b013e3181df0a1b.
8
Classification and pathology of primary progressive aphasia.
Neurology. 2013 Nov 19;81(21):1832-9. doi: 10.1212/01.wnl.0000436070.28137.7b. Epub 2013 Oct 18.
9
Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia.
Brain. 2022 Jun 30;145(6):2133-2148. doi: 10.1093/brain/awab410.
10
Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia.
Neurology. 2017 Jun 13;88(24):2276-2284. doi: 10.1212/WNL.0000000000004034. Epub 2017 May 17.

引用本文的文献

2
The role of nuclear medicine in central nervous system evaluation.
Neuroradiol J. 2025 Jun 25:19714009251345100. doi: 10.1177/19714009251345100.
3
Primary Progressive Aphasias: Diagnosis and Treatment.
Brain Sci. 2025 Feb 25;15(3):245. doi: 10.3390/brainsci15030245.
5
Multi-parametric [F]PI-2620 tau PET/MRI for the phenotyping of different Alzheimer's disease variants.
Eur J Nucl Med Mol Imaging. 2025 Feb 12. doi: 10.1007/s00259-025-07135-z.
7
Atypical Presentations of Alzheimer Disease.
Continuum (Minneap Minn). 2024 Dec 1;30(6):1614-1641. doi: 10.1212/CON.0000000000001504.
8
Functional correlates of executive dysfunction in primary progressive aphasia: a systematic review.
Front Aging Neurosci. 2024 Oct 18;16:1448214. doi: 10.3389/fnagi.2024.1448214. eCollection 2024.
9
Effects of Cerebellar Transcranial Direct Current Stimulation in Bilingual Logopenic Primary Progressive Aphasia.
J Alzheimers Dis Rep. 2024 Sep 18;8(1):1253-1273. doi: 10.3233/ADR-240034. eCollection 2024.
10
Cognitive reserve in individuals with frontotemporal dementia: a systematic review.
J Clin Exp Neuropsychol. 2024 Oct;46(8):718-741. doi: 10.1080/13803395.2024.2410207. Epub 2024 Oct 17.

本文引用的文献

1
Focal cortical presentations of Alzheimer's disease.
Brain. 2007 Oct;130(Pt 10):2636-45. doi: 10.1093/brain/awm213.
2
An update on primary progressive aphasia.
Curr Neurol Neurosci Rep. 2007 Sep;7(5):388-92. doi: 10.1007/s11910-007-0060-0.
3
Argyrophilic thorny astrocyte clusters in association with Alzheimer's disease pathology in possible primary progressive aphasia.
Acta Neuropathol. 2007 Oct;114(4):347-57. doi: 10.1007/s00401-007-0266-x. Epub 2007 Jul 19.
4
Abeta amyloid deposition in the language system and how the brain responds.
Brain. 2007 Aug;130(Pt 8):2055-69. doi: 10.1093/brain/awm133. Epub 2007 Jun 24.
5
Frontotemporal lobar degeneration: clinical and pathological relationships.
Acta Neuropathol. 2007 Jul;114(1):31-8. doi: 10.1007/s00401-007-0236-3. Epub 2007 Jun 14.
6
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.
Ann Neurol. 2007 May;61(5):435-45. doi: 10.1002/ana.21154.
7
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):210-6. doi: 10.1097/01.wad.0000213865.09806.92.
8
Clinical and pathological characterization of progressive aphasia.
Ann Neurol. 2006 Jan;59(1):156-65. doi: 10.1002/ana.20700.
9
The evolution and pathology of frontotemporal dementia.
Brain. 2005 Sep;128(Pt 9):1996-2005. doi: 10.1093/brain/awh598. Epub 2005 Jul 20.
10
Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.
Ann Neurol. 2005 May;57(5):721-9. doi: 10.1002/ana.20477.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验